Mario Enrico Canonico/LinkedIn
Aug 20, 2026, 13:46
Mario Enrico Canonico։ CLEAR Outcomes Analysis Highlights Bempedoic Acid Benefits in PAD
Mario Enrico Canonico, Assistant Research Professor of Medicine at University of Colorado, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
”Excited to share our analysis from the CLEAR Outcomes trial, led by Marc Bonaca, now published in Circulation!
Bempedoic acid reduced MACE and MALE in patients with PAD.”
Title: Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial
Authors: Marc P. Bonaca, Mario Enrico Canonico, Na Li, William J. Sasiela, Steven E. Nissen, A. Michael Lincoff, Stephen J. Nicholls
Stay updated on the latest scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis